Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Smart anticancer nanofibers: Setting treatments to work together

Design concept for a smart hyperthermia nanofiber system that uses magnetic nanoparticles (MNPs) dispersed in temperature-responsive polymers. Anticancer drug, doxorubicin (DOX), is also incorporated into the nanofibers. The nanofibers are chemically crosslinked. First, the device signal (alternating magnetic field, AMF) is turned 'on' to activate the MNPs in the nanofibers. Then, the MNPs generate heat to collapse the polymer networks in the nanofiber, allowing the 'on-off' release of DOX. Both the generated heat and released DOX induce apoptosis of cancer cells by hyperthermic and chemotherapeutic effects, respectively.
Design concept for a smart hyperthermia nanofiber system that uses magnetic nanoparticles (MNPs) dispersed in temperature-responsive polymers. Anticancer drug, doxorubicin (DOX), is also incorporated into the nanofibers. The nanofibers are chemically crosslinked. First, the device signal (alternating magnetic field, AMF) is turned 'on' to activate the MNPs in the nanofibers. Then, the MNPs generate heat to collapse the polymer networks in the nanofiber, allowing the 'on-off' release of DOX. Both the generated heat and released DOX induce apoptosis of cancer cells by hyperthermic and chemotherapeutic effects, respectively.

Abstract:
MANA researchers report that incorporating magnetic nanoparticles and an anticancer drug into crosslinked polymer nanofibers presents a twofold treatment for fighting cancer with diminished side effects.

Smart anticancer nanofibers: Setting treatments to work together

Tsukuba, Japan | Posted on July 15th, 2013

Stimuli-responsive or ‘smart' polymeric nanofi bers have attracted increasing attention. The nanoscale structures give rise to high sensitivity to stimuli while they can also be manipulated easily as macroscopic materials. Now researchers at the University of Tsukuba and the National Institute of Materials Science in Japan have demonstrated how they can be used to host magnetic nanoparticles to exploit hyperthermal effects for treating cancer while avoiding the usual side-effects. The incorporation of doxorubicin in the nanofibers as well allows controlled release of the anticancer drug as an additional mechanism for killing cancer cells.

Magnetic nanoparticles can kill cancer cells through the heat generated by induction when subjected to an alternating magnetic field. Such hyperthermal treatments have also been shown to improve the efficacy of anticancer drugs. However the nanoparticles can also lead to impaired mitochondrial function, inflammation, and DNA damage. Incorporating the nanoparticles into nanofibers may provide a solution.

Young-Jin Kim , Mitsuhiro Ebara , and Takao Aoyagi electrspun the fibers from a solution of the polymer poly(NIPAAm- co -HMAAm) mixed with a solution of magnetic nanoparticles and doxorubicin. The heating caused by the nanoparticles when switching on an alternating magnetic field caused hyperthermal effects, as well as reversible deswelling and deformation of the fibers, which released the drug molecules. Investigations in vitro and in cell lines demonstrated effective killing of cancer cells, which was greatly reduced for hyperthermal treatments alone in the absence of doxorubicin.

"The doxorubicin/magnetic-nanoparticles nanofi ber induced the apoptosis of cancer cells due to a synergistic effect of chemotherapy and hyperthermia," say the authors. The work demonstrates how smart nanofibers have potential for use as a manipulative material that combines hyperthermia and drug release treatments that can be controlled with the simple switching on or off of an alternating magnetic field.

Reference

A smart hyperthermia nanofi ber with switchable drug release for inducing cancer apoptosis Young-Jin Kim1,2, Mitsuhiro Ebara1 , and Takao Aoyagi1,2 *,2013 Adv. Funct. Mater. doi: 10.1002/adfm.201300746 .

Affiliations

Materials and Science Engineering Graduate School of Pure and Applied Science University of Tsukuba 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8577, Japan

Biomaterials Unit International Center for Materials Nanoarchitectonics (WPI-MANA) National Institute for Materials Science (NIMS) 1-1 Namiki, Tsukuba, Ibaraki 305-0044, Japan

*Corresponding author:

####

About International Center for Materials Nanoarchitectonics at NIMS
The International Center for Materials Nanoarchitectonics (MANA) was one of the five research centers selected by Japan's Ministry of Education, Culture, Sports, Science and Technology (MEXT) for the World Premier International (WPI) Research Center Initiative in 2007. The aim of the WPI is to create new world-class research facilities sufficiently attractive to prompt outstanding researchers from around the world to want to work in them, and MANA was established under this premise to encourage proactive science and technology research with a team of excellent researchers. MANA has been called one of Japan's best research institutes not only for its research output, but also for its efforts to internationalize and establish effective programs for training young researchers.

For more information, please click here

Contacts:
International Center for Materials Nanoarchitectonics(WPI-MANA)

1-1 Namiki, Tsukuba-shi Ibaraki, 305-0044 Japan
Jonathan.Hillnims.go.jp and ARIGA.Katsuhikonims.go.jp
Telephone: +81-29-860-3354

Copyright © International Center for Materials Nanoarchitectonics at NIM

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Nanomedicine

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

Discoveries

Breaking carbon–hydrogen bonds to make complex molecules November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project